These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12915346)

  • 21. [Sickle cell disease in heel injection screening. II].
    Vansenne F; de Borgie CA; Bouva MJ; Legdeur MA; van Zwieten R; Petrij F; Peters M
    Ned Tijdschr Geneeskd; 2009 May; 153(18):858-61. PubMed ID: 19475864
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sickle cell disease in heel injection screening. I].
    Peters M; Appel IM; Cnossen MH; Breuning-Boers JM; Heijboer H
    Ned Tijdschr Geneeskd; 2009 May; 153(18):854-7. PubMed ID: 19475863
    [No Abstract]   [Full Text] [Related]  

  • 23. [Recognition of children with sickle cell disease in The Netherlands].
    Heijboer H; Van den Tweel XW; Fijnvandraat K; Peters M
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2498-501. PubMed ID: 18062592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sickle cell disease: comprehensive screening and management in newborns and infants. Agency for Health Care Policy and Research.
    Clin Pract Guidel Quick Ref Guide Clin; 1993 Apr; (6):1-13. PubMed ID: 8485604
    [No Abstract]   [Full Text] [Related]  

  • 25. Neonatal screening for sickle cell disorders in Ouagadougou, Burkina Faso: a pilot study.
    Kafando E; Sawadogo M; Cotton F; Vertongen F; Gulbis B
    J Med Screen; 2005; 12(3):112-4. PubMed ID: 16156939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal haemoglobinopathy screening in Belgium.
    Gulbis B; Cotton F; Ferster A; Ketelslegers O; Dresse MF; Rongé-Collard E; Minon JM; Lé PQ; Vertongen F
    J Clin Pathol; 2009 Jan; 62(1):49-52. PubMed ID: 19103861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
    Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
    J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sickle cell disease in North Europe.
    Howard J; Davies SC
    Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newborn metabolic disorder screening program: sickle cell disease and other hemoglobinopathies.
    Parkhurst J
    J Okla State Med Assoc; 1997; 90(6):256-7. PubMed ID: 9299899
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neonatal screening of sickle cell anemia in metropolitan France].
    Bardakjian J; Benkerrou M; Bernaudin F; Briard ML; Ducrocq R; Lambilliotte A; Léna-Russo D; de Montalembert M; Thuret I; Bégué P; Elion J; Galactéros F;
    Arch Pediatr; 2000 Dec; 7(12):1261-3. PubMed ID: 11147058
    [No Abstract]   [Full Text] [Related]  

  • 31. Nurses are key to sickle cell screening.
    Anionwu E
    Nurs Times; 2004 Aug 31-Sep 6; 100(35):18. PubMed ID: 15471262
    [No Abstract]   [Full Text] [Related]  

  • 32. Prophylaxis crucial in sickle cell disease.
    Roberts-Harewood M; Davies SC
    Practitioner; 2007 Jul; 251(1696):55, 57, 59-61. PubMed ID: 17784665
    [No Abstract]   [Full Text] [Related]  

  • 33. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels.
    Gulbis B; Ferster A; Cotton F; Lebouchard MP; Cochaux P; Vertongen F
    J Med Screen; 2006; 13(2):76-8. PubMed ID: 16792829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sickle cell disease: exotic disease or a Belgian public health problem?].
    Gulbis B; Ferster A; Kentos A; N'Gay Munungi D; Cotton F; Rongé E; Dresse MF; Bradstreet C; Cochaux P; Vertongen F
    Rev Med Brux; 2005 Sep; 26(4):S309-13. PubMed ID: 16240879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn hemoglobinopathy screening in Tennessee--current status.
    Wang WC
    J Tenn Med Assoc; 1989 Sep; 82(9):473-6. PubMed ID: 2796334
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evidence for the widespread use of neonatal screening for sickle cell disease].
    Cavazzana M; Stanislas A; Rémus C; Duwez P; Renoult J; Cretet J; Fernandes S; Le Mée C; Allaf B; Porquet D; Munnich A; Polak M; Gauthereau V; Girot R
    Med Sci (Paris); 2018 Apr; 34(4):309-311. PubMed ID: 29658472
    [No Abstract]   [Full Text] [Related]  

  • 37. Haemoglobinopathies and newborn haemoglobinopathy screening in Germany.
    Dickerhoff R; Genzel-Boroviczeny O; Kohne E
    J Clin Pathol; 2009 Jan; 62(1):34. PubMed ID: 19103856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
    Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening newborn infants for sickle cell disease: participation of comprehensive centers for sickle cell disease.
    Scott RB
    Am J Pediatr Hematol Oncol; 1988; 10(1):3-4. PubMed ID: 3189714
    [No Abstract]   [Full Text] [Related]  

  • 40. Sickle cell disease: screening and counselling in the antenatal and neonatal period. Part 2.
    Anionwu EN
    Midwife Health Visit Community Nurse; 1983 Nov; 19(11):440-3. PubMed ID: 6559254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.